Market access and HTA
Beyond achieving regulatory approval, the success of a drug or device depends on its ability to demonstrate tangible value to payers and healthcare providers.
Auxa Life Sciences is unique from other agencies in that it offers a full spectrum medical writing service under one roof. In addition to regulatory applications, the team at Auxa Life Sciences possess extensive experience in market access consulting, preparation of payer engagement and value communication materials, and writing submissions for health technology assessment (HTA) bodies. Auxa Life Sciences is thus uniquely positioned to support you in preparing the full suite of documentation required to bring your treatment through clinical development to marketing authorisation, and from positive HTA appraisal to optimised access by patients.
Global value dossiers
We can author (or update) your global value dossier, consolidating your clinical, humanistic, and economic evidence into an impactful and standardised master narrative that supports your market access activities globally.
HTA submissions
With extensive experience preparing HTA submissions (in particular NICE and SMC), we will expertly compile your systematic reviews, clinical trial data, meta-analyses, and economic model into an articulate and compelling submission for reimbursement appraisal.
Value propositions and slide decks
We work closely with you to formulate and refine a compelling value story, ensuring every claim is backed by evidence and pressure-tested for the market. We are experts at translating complex clinical, humanistic, and economic data into clear, visually engaging slide decks designed for effective payer engagement.
Objection handlers
We proactively identify potential barriers to access by anticipating payer concerns and objections. We then develop a robust and comprehensive objection handler that addresses each anticipated challenge to clinical evidence, cost-effectiveness, and budget impact, with precision and clarity. By synthesising vast datasets into concise, defensible responses, we equip your team with the evidence required to navigate difficult negotiations and secure favourable positioning for your treatment.
